Biweekly fotemustine schedule for recurrent glioblastoma in the elderly: activity and toxicity assessment of a multicenter study

AIM: To assess the efficacy and safety of alternative fotemustine administration schedule in elderly patients with recurrent glioblastoma. PATIENTS & METHODS: Patients aged >65 years with recurrent glioblastoma received fotemustine (80 mg/m(2); days 1, 15, 30, 45 and 60, and subsequently ever...

Descripción completa

Detalles Bibliográficos
Autores principales: Addeo, Raffaele, Lamberti, Giuseppe, Simonetti, Giorgia, Iodice, Patrizia, Marinelli, Alfredo, Montella, Liliana, Cappabianca, Salvatore, Gaviani, Paola, Caraglia, Michele, Prete, Salvatore Del, Silvani, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713024/
https://www.ncbi.nlm.nih.gov/pubmed/31290692
http://dx.doi.org/10.2217/cns-2019-0004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713024/
https://www.ncbi.nlm.nih.gov/pubmed/31290692
http://dx.doi.org/10.2217/cns-2019-0004

Ejemplares similares